Financial Ratios Sernova Toronto S.E.
Stocks
SVA
CA81732W1041
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | -8.33% |
|
-4.35% | -15.38% |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -24.39 | -37.59 | -67.87 | -133.56 | -226.48 | |||||
Return on Total Capital | -26.03 | -40.53 | -83.63 | -14.99K | 57.45 | |||||
Return On Equity % | -43.25 | -64.54 | -129.73 | 14.56K | 82.79 | |||||
Return on Common Equity | -43.25 | -64.54 | -129.73 | 14.56K | 82.79 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 19.19 | 10.78 | 2.19 | 0.32 | 0.02 | |||||
Quick Ratio | 19.19 | 10.74 | 2.17 | 0.32 | 0.02 | |||||
Operating Cash Flow to Current Liabilities | -4.64 | -3.04 | -3.16 | -0.94 | -0.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.4 | 0.58 | 1.09 | -4.4 | -19.04 | |||||
Total Debt / Total Capital | 1.38 | 0.58 | 1.08 | -4.6 | -23.51 | |||||
LT Debt/Equity | 0.98 | 0.29 | - | -3.62 | -4.16 | |||||
Long-Term Debt / Total Capital | 0.97 | 0.28 | - | -3.78 | -5.14 | |||||
Total Liabilities / Total Assets | 5.87 | 9.29 | 43.39 | 272.13 | 3.38K | |||||
EBIT / Interest Expense | -201.81 | -483.61 | -1.26K | -53.95 | -19.9 | |||||
EBITDA / Interest Expense | -194.03 | -475.02 | -1.25K | -53.03 | -19.45 | |||||
(EBITDA - Capex) / Interest Expense | -194.53 | -481.45 | -1.25K | -53.03 | -19.45 | |||||
Total Debt / EBITDA | -0.06 | -0.01 | -0 | -0.02 | -0.33 | |||||
Net Debt / EBITDA | 4.12 | 2.04 | 0.49 | 0.17 | -0.31 | |||||
Total Debt / (EBITDA - Capex) | -0.06 | -0.01 | -0 | -0.02 | -0.33 | |||||
Net Debt / (EBITDA - Capex) | 4.11 | 2.01 | 0.49 | 0.17 | -0.31 | |||||
Growth Over Prior Year | ||||||||||
EBITDA, 1 Yr. Growth % | 30.63 | 265.37 | 64.38 | -22.24 | -52.75 | |||||
EBITA, 1 Yr. Growth % | 30.14 | 264.49 | 64.14 | -22.22 | -52.08 | |||||
EBIT, 1 Yr. Growth % | 31.88 | 256.86 | 63.62 | -21.82 | -52.55 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 30.9 | 250.59 | 59.69 | -17.45 | -51.1 | |||||
Net Income, 1 Yr. Growth % | 30.9 | 250.59 | 59.69 | -17.45 | -51.1 | |||||
Normalized Net Income, 1 Yr. Growth % | 30.9 | 250.59 | 59.69 | -17.42 | -50.97 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 5.18 | 214.62 | 44.04 | -18.43 | -54.27 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 177.58 | 15.77 | -22.37 | 64.34 | -97.87 | |||||
Total Assets, 1 Yr. Growth % | 420.83 | 76 | -57.88 | -65.95 | -89.85 | |||||
Tangible Book Value, 1 Yr. Growth % | 747.32 | 72.17 | -74.1 | -206.22 | 93.54 | |||||
Common Equity, 1 Yr. Growth % | 577.19 | 69.62 | -73.71 | -203.53 | 93.54 | |||||
Cash From Operations, 1 Yr. Growth % | 73.73 | 110.72 | 110.38 | -37.72 | -42.27 | |||||
Capital Expenditures, 1 Yr. Growth % | 215.2 | 1.81K | -69.83 | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 36.95 | 74.31 | 190.09 | -58.76 | -14.93 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 36.27 | 73.65 | 191.41 | -60.99 | -17.47 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
EBITDA, 2 Yr. CAGR % | 30.22 | 118.47 | 145.07 | 13.06 | -39.39 | |||||
EBITA, 2 Yr. CAGR % | 29.64 | 117.79 | 144.59 | 12.99 | -38.95 | |||||
EBIT, 2 Yr. CAGR % | 31.55 | 116.94 | 141.64 | 13.1 | -39.1 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.44 | 114.22 | 136.61 | 14.81 | -36.46 | |||||
Net Income, 2 Yr. CAGR % | 32.44 | 114.22 | 136.61 | 14.81 | -36.46 | |||||
Normalized Net Income, 2 Yr. CAGR % | 32.44 | 114.22 | 136.61 | 14.84 | -36.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 12.09 | 81.91 | 112.88 | 8.4 | -38.92 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 49.84 | 79.26 | -5.2 | 12.95 | -81.31 | |||||
Total Assets, 2 Yr. CAGR % | 131.41 | 202.77 | -13.9 | -62.13 | -81.41 | |||||
Tangible Book Value, 2 Yr. CAGR % | 136.7 | 281.95 | -33.22 | -47.55 | 43.38 | |||||
Common Equity, 2 Yr. CAGR % | 139.79 | 238.91 | -33.23 | -47.83 | 41.56 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.77 | 91.34 | 110.55 | 14.47 | -40.04 | |||||
Capital Expenditures, 2 Yr. CAGR % | -15.27 | 675.82 | 140.02 | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 20.96 | 54.14 | 124.87 | 9.38 | -40.77 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 20.68 | 53.83 | 124.95 | 6.63 | -43.26 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
EBITDA, 3 Yr. CAGR % | 22.48 | 83.66 | 98.71 | 67.15 | -15.47 | |||||
EBITA, 3 Yr. CAGR % | 22.04 | 82.97 | 98.2 | 66.95 | -15.11 | |||||
EBIT, 3 Yr. CAGR % | 23.23 | 83.47 | 97.47 | 65.88 | -15.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 23.49 | 83.21 | 94.24 | 66.57 | -13.61 | |||||
Net Income, 3 Yr. CAGR % | 23.49 | 83.21 | 94.24 | 66.57 | -13.61 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.49 | 83.21 | 94.24 | 66.59 | -13.53 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.95 | 58.12 | 68.29 | 54.62 | -18.7 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 25.02 | 37.49 | 35.62 | 13.88 | -69.96 | |||||
Total Assets, 3 Yr. CAGR % | 102.24 | 111.23 | 56.88 | -36.8 | -75.58 | |||||
Tangible Book Value, 3 Yr. CAGR % | 103.12 | 112.87 | 55.76 | -22.05 | -18.95 | |||||
Common Equity, 3 Yr. CAGR % | 104.88 | 113.65 | 44.53 | -22.72 | -19.24 | |||||
Cash From Operations, 3 Yr. CAGR % | 20.45 | 50.96 | 97.48 | 40.29 | -8.89 | |||||
Capital Expenditures, 3 Yr. CAGR % | -46.89 | 139.33 | 162.85 | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.72 | 36.41 | 90.31 | 27.76 | 0.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.57 | 36.24 | 90.34 | 25.45 | -2.1 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
EBITDA, 5 Yr. CAGR % | 21.82 | 56.51 | 61.65 | 51.26 | 23.58 | |||||
EBITA, 5 Yr. CAGR % | 21.91 | 56.17 | 61.17 | 50.89 | 23.75 | |||||
EBIT, 5 Yr. CAGR % | 22.63 | 56.42 | 61.33 | 51.19 | 23.36 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.75 | 56.04 | 60.18 | 51.97 | 24.23 | |||||
Net Income, 5 Yr. CAGR % | 22.75 | 56.04 | 60.18 | 51.97 | 24.23 | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.75 | 56.04 | 60.18 | 51.98 | 24.3 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.93 | 39.86 | 40.85 | 35.95 | 12.2 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 84.17 | 22.35 | 11.92 | 27.09 | -38.62 | |||||
Total Assets, 5 Yr. CAGR % | 36.8 | 63.07 | 43.72 | 6.21 | -33.15 | |||||
Tangible Book Value, 5 Yr. CAGR % | 38.44 | 66.77 | 30.17 | 21.56 | 50.68 | |||||
Common Equity, 5 Yr. CAGR % | 39.16 | 67.14 | 30.84 | 21.56 | 43.34 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.8 | 39.39 | 50.6 | 35.14 | 22.59 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.39 | 5.5 | -2.91 | - | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 59.07 | 26 | 47.65 | 24.88 | 19.31 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 58.85 | 25.86 | 47.69 | 23.52 | 17.3 |
- Stock Market
- Stocks
- SVA Stock
- SVA Stock
- Financials Sernova
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















